Theranostics 2020; 10(11):4809-4821. doi:10.7150/thno.44376 This issue Cite

Research Paper

Light-activated gold nanorod vesicles with NIR-II fluorescence and photoacoustic imaging performances for cancer theranostics

Xiaoguang Ge, Qinrui Fu, Lichao Su, Zhi Li, Wenmin Zhang, Tao Chen, Huanghao Yang, Jibin Song

MOE key Laboratory for Analytical Science of Food Safety and Biology, College of Chemistry, Fuzhou University, Fuzhou 350108, China

Citation:
Ge X, Fu Q, Su L, Li Z, Zhang W, Chen T, Yang H, Song J. Light-activated gold nanorod vesicles with NIR-II fluorescence and photoacoustic imaging performances for cancer theranostics. Theranostics 2020; 10(11):4809-4821. doi:10.7150/thno.44376. https://www.thno.org/v10p4809.htm
Other styles

File import instruction

Abstract

Graphic abstract

Fluorescence (FL) and photoacoustic (PA) imaging in the second near infrared window (NIR-II FL and NIR-II PA) hold great promise for biomedical applications because of their non-invasive nature and excellent spatial resolution properties.

Methods: We develop a NIR-II PA and NIR-II FL dual-mode imaging gold nanorod vesicles (AuNR Ves) by self-assembly of amphiphilic AuNR coated with light responsive polyprodrug of Ru-complex and PEG, and NIR-II cyanine dye (IR 1061). The AuNR Ves showed strong ligh absorption property and PA imaging performance in the NIR-II windows. Moreover, the NIR-II fluorescence signal of IR 1061 loaded in the AuNR Ve is quenched.

Results: The AuNR Ves can release photosensitizer Ru-complex and IR 1061 sequentially triggered by NIR light irradiation, leading to a corresponding NIR-II PA signal decrease and NIR-II FL signal recovery. Meanwhile, Ru-complex can not only serve as a chemotherapeutic drug but also generate singlet oxygen (1O2) under NIR light irradiation. The release of Ru-complex and photodynamic therapy are guided by the responsive variation of NIR-II PA and NIR-II FL signals.

Conclusions: The AuNR Ve possessing not only precisely control 1O2/drug release but also the intrinsic ability to monitor therapy process offers a new strategy for the development of smart theranostic nanoplatform.

Keywords: metallodrugs, second near infrared window, photoacoustic imaging, fluorescence imaging, gold nanorod vesicle


Citation styles

APA
Ge, X., Fu, Q., Su, L., Li, Z., Zhang, W., Chen, T., Yang, H., Song, J. (2020). Light-activated gold nanorod vesicles with NIR-II fluorescence and photoacoustic imaging performances for cancer theranostics. Theranostics, 10(11), 4809-4821. https://doi.org/10.7150/thno.44376.

ACS
Ge, X.; Fu, Q.; Su, L.; Li, Z.; Zhang, W.; Chen, T.; Yang, H.; Song, J. Light-activated gold nanorod vesicles with NIR-II fluorescence and photoacoustic imaging performances for cancer theranostics. Theranostics 2020, 10 (11), 4809-4821. DOI: 10.7150/thno.44376.

NLM
Ge X, Fu Q, Su L, Li Z, Zhang W, Chen T, Yang H, Song J. Light-activated gold nanorod vesicles with NIR-II fluorescence and photoacoustic imaging performances for cancer theranostics. Theranostics 2020; 10(11):4809-4821. doi:10.7150/thno.44376. https://www.thno.org/v10p4809.htm

CSE
Ge X, Fu Q, Su L, Li Z, Zhang W, Chen T, Yang H, Song J. 2020. Light-activated gold nanorod vesicles with NIR-II fluorescence and photoacoustic imaging performances for cancer theranostics. Theranostics. 10(11):4809-4821.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image